As experience with these novel antihyperglycemic drugs increases, future studies with longer follow-up periods should be conducted to corroborate our findings. Patients were followed from cohort ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

GLP-1RAs are antihyperglycemic agents with protective ... GLP-1RAs would positively help physicians prescribe this class of drug for treatment. The current study used a discovery approach to ...

(2009) T2DM drug-naive patients (n = 389 ... Adverse events; AHA: Antihyperglycemic agents; BUN: Blood urea nitrogen; CANA: Canagliflozin; eGFR Estimated glomerular filtration rate; FPG: Fasting ...

Unlike many other drugs used to treat diabetes ... 2-h PPG (adjusted mean*)-49-2 *Least square means adjusted for prior antihyperglycemic therapy status and baseline value. A1c: Hemoglobin ...

which included 215,970 new users of GLP-1 drugs with type 2 diabetes and 1,203,097 patients who received usual diabetes care with non-GLP-1 antihyperglycemic agents from October 2017 through ...

By Dr. Priyom Bose, Ph.D. Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and ...

Initially prescribed for type 2 diabetes (T2D), these drugs are now FDA-approved for ... Individuals with bariatric surgery, those prescribed an antihyperglycemic medication, and individuals ...

Patients with any prior history of any of the study drugs, a prior diagnosis of chronic liver disease, or other causes of cirrhosis (eg, biliary, infectious, or childhood cirrhosis) were excluded. As ...

Therefore, in the early stages of diabetes, curcumin can be used as a potential complementary treatment option in combination with antihyperglycemic drugs for more effective treatment of diabetic ...